HomeAboutRankingsData Sources
Β© 2026 GeneE
🧬
GeneE
10 sources retrieved Β· Most recent: April 2026 Β· Index updated 15 days ago
β“˜GeneE is for informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment.
DUOX2
dual oxidase 2
Chromosome 15 Β· 15q21.1
NCBI Gene: 50506Ensembl: ENSG00000140279.13HGNC: HGNC:13273UniProt: Q9NRD8
134PubMed Papers
21Diseases
0Drugs
239Pathogenic Variants
RESEARCH IMPACT
Variant-Rich
CLINICAL
OMIM Disease Gene
DATA QUALITY
βœ“ Experimental GO Evidenceβœ“ Swiss-Prot Reviewed
endoplasmic reticulumcell surfaceapical plasma membranecell leading edgefamilial thyroid dyshormonogenesiscongenital hypothyroidismgenetic disordergoiter
✦AI Summary

DUOX2 (dual oxidase 2) is a hydrogen peroxide-generating NADPH oxidase essential for thyroid hormone synthesis and mucosal immunity. Functionally, DUOX2 produces H2O2 required for thyroid peroxidase activity in thyroid hormone synthesis 1 and supports lactoperoxidase-mediated antimicrobial defense at mucosal surfaces 2. DUOX2 also synthesizes NAADP to promote calcium signaling during T cell activation 3. Mechanistically, DUOX2 operates through hydrogen peroxide biosynthesis and superoxide generation via its NAD(P)H oxidase activity, localized to apical plasma membranes and extracellular compartments. Clinically, DUOX2 mutations are the leading genetic cause of congenital hypothyroidism (CH) in Chinese populations, present in 21-35% of cases 45. DUOX2 biallelic mutations predominantly cause dyshormonogenesis-related CH with goiter phenotype 6, and residual enzymatic activity ≀22% correlates with more severe hypothyroidism 7. Beyond thyroid disease, DUOX2 variants associate with inflammatory bowel disease risk through disrupted microbiota-immune homeostasis and elevated IL-17C 8. Additionally, DUOX2+ cholangiocytes are pathogenic targets in primary biliary cholangitis 9, and DUOX2 expression elevation via cGAS-STING activation promotes pancreatic cancer progression 10. DUOX2 emerges as both a therapeutic target and diagnostic biomarker across multiple inflammatory and neoplastic conditions.

Sources cited
1
Functionally, DUOX2 produces H2O2 required for thyroid peroxidase activity in thyroid hormone synthesis and supports lactoperoxidase-mediated antimicrobial defense at mucosal surfaces .
PMID: 15972824
2
Functionally, DUOX2 produces H2O2 required for thyroid peroxidase activity in thyroid hormone synthesis and supports lactoperoxidase-mediated antimicrobial defense at mucosal surfaces .
PMID: 12824283
3
DUOX2 also synthesizes NAADP to promote calcium signaling during T cell activation .
PMID: 34784249
4
DUOX2 biallelic mutations predominantly cause dyshormonogenesis-related CH with goiter phenotype , and residual enzymatic activity ≀22% correlates with more severe hypothyroidism .
PMID: 37390946
5
DUOX2 biallelic mutations predominantly cause dyshormonogenesis-related CH with goiter phenotype , and residual enzymatic activity ≀22% correlates with more severe hypothyroidism .
PMID: 34564849
6
Beyond thyroid disease, DUOX2 variants associate with inflammatory bowel disease risk through disrupted microbiota-immune homeostasis and elevated IL-17C .
PMID: 33651715
7
Additionally, DUOX2+ cholangiocytes are pathogenic targets in primary biliary cholangitis , and DUOX2 expression elevation via cGAS-STING activation promotes pancreatic cancer progression .
PMID: 36759512
8
Additionally, DUOX2+ cholangiocytes are pathogenic targets in primary biliary cholangitis , and DUOX2 expression elevation via cGAS-STING activation promotes pancreatic cancer progression .
PMID: 37330147
Disease Associationsβ“˜21
familial thyroid dyshormonogenesisOpen Targets
0.78Strong
congenital hypothyroidismOpen Targets
0.59Moderate
genetic disorderOpen Targets
0.53Moderate
goiterOpen Targets
0.38Weak
transient congenital hypothyroidismOpen Targets
0.37Weak
Iron deficiency anemiaOpen Targets
0.37Weak
permanent congenital hypothyroidismOpen Targets
0.37Weak
head injuryOpen Targets
0.18Weak
Basal ganglia calcificationOpen Targets
0.12Weak
bilateral striopallidodentate calcinosisOpen Targets
0.12Weak
neoplasmOpen Targets
0.09Suggestive
colorectal carcinomaOpen Targets
0.09Suggestive
ulcerative colitisOpen Targets
0.09Suggestive
colitisOpen Targets
0.08Suggestive
inflammatory bowel diseaseOpen Targets
0.08Suggestive
primary biliary cirrhosisOpen Targets
0.07Suggestive
necrotizing enterocolitisOpen Targets
0.07Suggestive
pachyonychia congenitaOpen Targets
0.07Suggestive
coxopodopatellar syndromeOpen Targets
0.07Suggestive
gastric cancerOpen Targets
0.07Suggestive
Thyroid dyshormonogenesis 6UniProt
Pathogenic Variants239
NM_001363711.2(DUOX2):c.2895_2898del (p.Phe966fs)Pathogenic
Familial thyroid dyshormonogenesis|not provided|Inborn genetic diseases|Nongoitrous Euthyroid Hyperthyrotropinemia|Congenital hypothyroidism|Thyroid dyshormonogenesis 6|DUOX2-related disorder|Familial thyroid dyshormonogenesis;Thyroid dyshormonogenesis 6
β˜…β˜…β˜†β˜†2026β†’ Residue 966
NM_001363711.2(DUOX2):c.602dup (p.Gln202fs)Pathogenic
not provided|Thyroid dyshormonogenesis 6|Congenital hypothyroidism|DUOX2-related disorder|Inborn genetic diseases|Thyroid dyshormonogenesis 6;Familial thyroid dyshormonogenesis
β˜…β˜…β˜†β˜†2026β†’ Residue 202
NM_001363711.2(DUOX2):c.2665G>T (p.Glu889Ter)Pathogenic
not provided|Thyroid dyshormonogenesis 6
β˜…β˜…β˜†β˜†2026β†’ Residue 889
NM_001363711.2(DUOX2):c.1588A>T (p.Lys530Ter)Pathogenic
not provided|Thyroid dyshormonogenesis 6|DUOX2-related disorder|Gastric cancer|Thyroid dyshormonogenesis 6;Familial thyroid dyshormonogenesis
β˜…β˜…β˜†β˜†2026β†’ Residue 530
NM_001363711.2(DUOX2):c.4524+1dupPathogenic
not provided|Thyroid dyshormonogenesis 6
β˜…β˜…β˜†β˜†2026
NM_001363711.2(DUOX2):c.4552G>A (p.Gly1518Ser)Pathogenic
not provided|DUOX2-related disorder|Thyroid dyshormonogenesis 6
β˜…β˜…β˜†β˜†2026β†’ Residue 1518
NM_001363711.2(DUOX2):c.3328C>T (p.Arg1110Ter)Pathogenic
not provided|Thyroid dyshormonogenesis 6|Thyroid dyshormonogenesis 6;Familial thyroid dyshormonogenesis|Congenital hypothyroidism
β˜…β˜…β˜†β˜†2026β†’ Residue 1110
NM_001363711.2(DUOX2):c.1478del (p.His493fs)Pathogenic
not provided
β˜…β˜…β˜†β˜†2026β†’ Residue 493
NM_001363711.2(DUOX2):c.3516_3531delPathogenic
not provided|Thyroid dyshormonogenesis 6
β˜…β˜…β˜†β˜†2026
NM_001363711.2(DUOX2):c.3693+1G>TPathogenic
not provided|Thyroid dyshormonogenesis 6|DUOX2-related disorder|Familial thyroid dyshormonogenesis;Thyroid dyshormonogenesis 6
β˜…β˜…β˜†β˜†2026
NM_001363711.2(DUOX2):c.3667del (p.His1223fs)Pathogenic
Thyroid dyshormonogenesis 6|not provided
β˜…β˜…β˜†β˜†2026β†’ Residue 1223
NM_001363711.2(DUOX2):c.3751del (p.Leu1251fs)Pathogenic
not provided|Thyroid dyshormonogenesis 6
β˜…β˜…β˜†β˜†2026β†’ Residue 1251
NM_001363711.2(DUOX2):c.513+1G>CPathogenic
Thyroid dyshormonogenesis 6|not provided
β˜…β˜…β˜†β˜†2026
NM_001363711.2(DUOX2):c.4081-1G>ALikely pathogenic
Thyroid dyshormonogenesis 6|not provided
β˜…β˜…β˜†β˜†2026
NM_001363711.2(DUOX2):c.1741C>T (p.Gln581Ter)Pathogenic
not provided|Thyroid dyshormonogenesis 6
β˜…β˜…β˜†β˜†2026β†’ Residue 581
NM_001363711.2(DUOX2):c.3250C>T (p.Arg1084Ter)Pathogenic
Thyroid dyshormonogenesis 6|not provided
β˜…β˜…β˜†β˜†2026β†’ Residue 1084
NM_001363711.2(DUOX2):c.2654G>A (p.Arg885Gln)Pathogenic
not provided|Thyroid dyshormonogenesis 6
β˜…β˜…β˜†β˜†2026β†’ Residue 885
NM_001363711.2(DUOX2):c.1275T>G (p.Tyr425Ter)Pathogenic
not provided|Thyroid dyshormonogenesis 6
β˜…β˜…β˜†β˜†2025β†’ Residue 425
NM_001363711.2(DUOX2):c.2635G>A (p.Glu879Lys)Pathogenic
Thyroid dyshormonogenesis 6|not provided|Inborn genetic diseases
β˜…β˜…β˜†β˜†2025β†’ Residue 879
NM_001363711.2(DUOX2):c.2907dup (p.Thr970fs)Pathogenic
not provided
β˜…β˜…β˜†β˜†2025β†’ Residue 970
View on ClinVar β†—
Related Genes
NOXO1Protein interaction100%NOX4Protein interaction99%NCF1Protein interaction99%NOX5Protein interaction99%CYBAProtein interaction95%CYBBProtein interaction95%
Tissue Expression6 tissues
Lung
100%
Liver
35%
Ovary
29%
Heart
25%
Bone Marrow
6%
Brain
6%
Gene Interaction Network
Click a node to explore
DUOX2NOXO1NOX4NCF1NOX5CYBACYBB
PROTEIN STRUCTURE
Preparing viewer…
AlphaFoldAI-predicted Β· UniProt Q9NRD8
View on AlphaFold β†—
Constraintβ“˜
LOEUFβ“˜
1.17LoF Tolerant
pLIβ“˜
0.00Tolerant
Observed/Expected LoF1.03 [0.91–1.17]
RankingsWhere DUOX2 stands among ~20K protein-coding genes
  • #3,457of 20,598
    Most Researched134 Β· top quartile
  • #265of 5,498
    Most Pathogenic Variants239 Β· top 5%
  • #12,178of 17,882
    Most Constrained (LOEUF)1.17
Genes detectedDUOX2
Sources retrieved10 papers
Response timeβ€”
πŸ“„ Sources
10β–Ό
1
PMID: 32425884
Front Endocrinol (Lausanne) Β· 2020
1.00
2
The genetic characteristics of congenital hypothyroidism in China by comprehensive screening of 21 candidate genes.
PMID: 29650690
Eur J Endocrinol Β· 2018
0.90
3
Correlation of DUOX2 residual enzymatic activity with phenotype in congenital hypothyroidism caused by biallelic DUOX2 defects.
PMID: 34564849
Clin Genet Β· 2021
0.80
4
Unique DUOX2
PMID: 36759512
Nat Commun Β· 2023
0.70
5
Biomarkers prediction and immune landscape in ulcerative colitis: Findings based on bioinformatics and machine learning.
PMID: 38070204
Comput Biol Med Β· 2024
0.60